Childhood immunisation against S. pneumoniae is the most effective public health measure for preventing IPD both among vaccine recipients (direct effect), and among unimmunised populations (indirect ‘herd’ effect).
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.
On 13 November, WHO reported 4 additional cases of cholera in Mexico. Since the beginning of the outbreak in September 2013, Mexico has reported 180 confirmed cases of cholera caused by Vibrio cholerae O:1 Ogawa, including one death.
On 1 October, 46 confirmed cases of cholera, including one death, were reported by the Pan American Health Organization (PAHO) in Mexico. Of those, two were identified in the Federal District and 44 in the state of Hidalgo.